Scoop: Deer­field and Dana-Far­ber forge clos­er ties to launch a new trans­la­tion­al can­cer re­search en­gine

A lit­tle over two years since first team­ing up on pro­tein degra­da­tion, Deer­field and Dana-Far­ber are putting their heads — and their wal­lets — to­geth­er again.

The pair is form­ing a new part­ner­ship in the form of River­way Dis­cov­er­ies, a trans­la­tion­al re­search en­gine aim­ing to boost ef­forts at get­ting pre­clin­i­cal can­cer work in­to hu­man stud­ies. Deer­field is putting up $130 mil­lion over the next 10 years to ad­vance such en­deav­ors, af­ter fund­ing the pro­tein degra­da­tion ef­fort for $80 mil­lion in late 2018.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER